Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

The interplay between MDV and HVT affects viral miRNa expression.

Goher M, Hicks JA, Liu HC.

Avian Dis. 2013 Jun;57(2 Suppl):372-9.

PMID:
23901749
2.

Current state of Marek's disease virus microRNA research.

Hicks JA, Liu HC.

Avian Dis. 2013 Jun;57(2 Suppl):332-9. Review.

PMID:
23901744
3.

Development, application, and results of routine monitoring of Marek's disease virus in broiler house dust using real-time quantitative PCR.

Walkden-Brown SW, Islam AF, Groves PJ, Rubite A, Sharpe SM, Burgess SK.

Avian Dis. 2013 Jun;57(2 Suppl):544-54.

PMID:
23901774
4.

Relationship between levels of very virulent MDV in poultry dust and in feather tips from vaccinated chickens.

Baigent SJ, Kgosana LB, Gamawa AA, Smith LP, Read AF, Nair VK.

Avian Dis. 2013 Jun;57(2 Suppl):440-7.

PMID:
23901759
5.

Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus.

Yu ZH, Teng M, Sun AJ, Yu LL, Hu B, Qu LH, Ding K, Cheng XC, Liu JX, Cui ZZ, Zhang GP, Luo J.

Virology. 2014 Jan 5;448:55-64. doi: 10.1016/j.virol.2013.09.017. Epub 2013 Oct 20.

6.

The significance of the individual Meq-clustered miRNAs of Marek's disease virus in oncogenesis.

Teng M, Yu ZH, Sun AJ, Min YJ, Chi JQ, Zhao P, Su JW, Cui ZZ, Zhang GP, Luo J.

J Gen Virol. 2015 Mar;96(Pt 3):637-49. doi: 10.1099/jgv.0.000013. Epub 2014 Dec 12.

PMID:
25502647
7.

Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis.

Renz KG, Cheetham BF, Walkden-Brown SW.

J Virol Methods. 2013 Jan;187(1):144-52. doi: 10.1016/j.jviromet.2012.09.018. Epub 2012 Oct 3.

PMID:
23041147
8.

Targeting Marek's disease virus by RNA interference delivered from a herpesvirus vaccine.

Lambeth LS, Zhao Y, Smith LP, Kgosana L, Nair V.

Vaccine. 2009 Jan 7;27(2):298-306. doi: 10.1016/j.vaccine.2008.10.023. Epub 2008 Oct 31.

PMID:
18977264
9.

Absolute quantification of a very virulent Marek's disease virus dynamic quantity and distributions in different tissues.

Zhang Z, Liu S, Ma C, Zhao P, Cui Z.

Poult Sci. 2015 Jun;94(6):1150-7. doi: 10.3382/ps/pev063. Epub 2015 Mar 31.

PMID:
25834249
10.

mdv1-miR-M7-5p, located in the newly identified first intron of the latency-associated transcript of Marek's disease virus, targets the immediate-early genes ICP4 and ICP27.

Strassheim S, Stik G, Rasschaert D, Laurent S.

J Gen Virol. 2012 Aug;93(Pt 8):1731-42. doi: 10.1099/vir.0.043109-0. Epub 2012 Apr 18.

PMID:
22513387
12.

Modulation of microRNAs in two genetically disparate chicken lines showing different necrotic enteritis disease susceptibility.

Dinh H, Hong YH, Lillehoj HS.

Vet Immunol Immunopathol. 2014 May 15;159(1-2):74-82. doi: 10.1016/j.vetimm.2014.02.003. Epub 2014 Feb 8.

PMID:
24629767
13.

Small RNA cloning and sequencing strategy affects host and viral microRNA expression signatures.

Stik G, Muylkens B, Coupeau D, Laurent S, Dambrine G, Messmer M, Chane-Woon-Ming B, Pfeffer S, Rasschaert D.

J Biotechnol. 2014 Jul 10;181:35-44. doi: 10.1016/j.jbiotec.2014.04.005. Epub 2014 Apr 16.

PMID:
24746587
14.

gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation.

Li X, Lian L, Zhang D, Qu L, Yang N.

Poult Sci. 2014 May;93(5):1097-105. doi: 10.3382/ps.2013-03656.

PMID:
24795301
15.

The inhibitory effects of gga-miR-199-3p, gga-miR-140-3p, and gga-miR-221-5p in Marek's disease tumorigenesis.

Lian L, Zhang D, Wang Q, Yang N, Qu L.

Poult Sci. 2015 Sep;94(9):2131-5. doi: 10.3382/ps/pev175. Epub 2015 Jun 25.

PMID:
26112035
16.
17.
18.

A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.

Lian L, Qu L, Chen Y, Lamont SJ, Yang N.

PLoS One. 2012;7(11):e51003. doi: 10.1371/journal.pone.0051003. Epub 2012 Nov 30.

19.

Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.

Haq K, Elawadli I, Parvizi P, Mallick AI, Behboudi S, Sharif S.

Antiviral Res. 2011 Jun;90(3):218-26. doi: 10.1016/j.antiviral.2011.04.001. Epub 2011 Apr 8.

PMID:
21501630
20.

A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumor development in chickens.

Parvizi P, Mallick AI, Haq K, Haghighi HR, Orouji S, Thanthrige-Don N, St Paul M, Brisbin JT, Read LR, Behboudi S, Sharif S.

Viral Immunol. 2012 Oct;25(5):394-401. doi: 10.1089/vim.2012.0033. Epub 2012 Aug 2.

PMID:
22857262

Supplemental Content

Support Center